Company Performance Metrics
- Erez Eitan: CSO
- Oded Biran: CEO and Co-Founder
NeuroDex is a developer of diagnostics, theranostics, prognostics, and pharmacodynamic analysis in the neurology space. The company's proprietary neuron-derived exosome isolation technology can be applied across a number of neurological indications. With the technology, a simple blood draw could allow physicians and researchers to open a
window into the brain.
NeuroDex's technology has the potential to enable early detection, patient stratification, and disease monitoring, which will enable the first disease-modifying treatment for Alzheimer's.